JP2024511479A5 - - Google Patents
Info
- Publication number
- JP2024511479A5 JP2024511479A5 JP2023559015A JP2023559015A JP2024511479A5 JP 2024511479 A5 JP2024511479 A5 JP 2024511479A5 JP 2023559015 A JP2023559015 A JP 2023559015A JP 2023559015 A JP2023559015 A JP 2023559015A JP 2024511479 A5 JP2024511479 A5 JP 2024511479A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163166793P | 2021-03-26 | 2021-03-26 | |
| US63/166,793 | 2021-03-26 | ||
| PCT/US2022/022041 WO2022204568A1 (en) | 2021-03-26 | 2022-03-25 | Maytansine-antibody conjugates and methods of using same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024511479A JP2024511479A (ja) | 2024-03-13 |
| JP2024511479A5 true JP2024511479A5 (https=) | 2025-04-01 |
| JPWO2022204568A5 JPWO2022204568A5 (https=) | 2025-04-01 |
Family
ID=83397950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023559015A Pending JP2024511479A (ja) | 2021-03-26 | 2022-03-25 | メイタンシン抗体コンジュゲートおよびそれを使用する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240156978A1 (https=) |
| EP (1) | EP4313009A4 (https=) |
| JP (1) | JP2024511479A (https=) |
| CN (1) | CN117412741A (https=) |
| AU (1) | AU2022245388A1 (https=) |
| CA (1) | CA3213065A1 (https=) |
| WO (1) | WO2022204568A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015054427A1 (en) * | 2013-10-10 | 2015-04-16 | Beth Israel Deaconess Medical Center, Inc. | Tm4sf1 binding proteins and methods of using same |
| WO2015081282A1 (en) * | 2013-11-27 | 2015-06-04 | Redwood Bioscience, Inc. | Hydrazinyl-pyrrolo compounds and methods for producing a conjugate |
| CN109265546B (zh) * | 2017-07-17 | 2022-05-24 | 同济大学苏州研究院 | 用于治疗癌症的新靶标 |
| MX2020002241A (es) * | 2017-08-28 | 2020-09-03 | Angiex Inc | Anticuerpos anti-tm4sf y métodos de uso de los mismos. |
| US12428477B2 (en) * | 2019-02-27 | 2025-09-30 | Angiex, Inc. | Antibody-drug conjugates comprising anti-TM4SF1 antibodies and methods of using the same |
-
2022
- 2022-03-25 AU AU2022245388A patent/AU2022245388A1/en active Pending
- 2022-03-25 CN CN202280038264.9A patent/CN117412741A/zh active Pending
- 2022-03-25 EP EP22776761.3A patent/EP4313009A4/en active Pending
- 2022-03-25 WO PCT/US2022/022041 patent/WO2022204568A1/en not_active Ceased
- 2022-03-25 JP JP2023559015A patent/JP2024511479A/ja active Pending
- 2022-03-25 CA CA3213065A patent/CA3213065A1/en active Pending
-
2023
- 2023-09-25 US US18/473,517 patent/US20240156978A1/en active Pending